Stem-cell therapy has the potential to regenerate tissue and cure disease—an approach preferable to many current treatments that simply mitigate symptoms. Currently, there is no approved medical therapy for Peyronie disease; a recent study suggests stem cells could provide an intriguing treatment option for this difficult-to-treat tissue defect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Castiglione, F. et al. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. Eur. Urol. doi:10.1016/j.eururo.2012.09.034.
Chamberlain, G., Fox, J., Ashton, B. & Middleton, J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739–2749 (2007).
Lin, C. S., Lin, G. & Lue, T. F. Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev. 21, 2770–2778 (2012).
Lin, C. S. et al. Defining adipose tissue-derived stem cells in tissue and in culture. Histol. Histopathol. 25, 807–815 (2010).
Huang, Y. C. et al. The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J. Sex. Med. 7, 1391–1400 (2010).
Albersen, M. et al. Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J. Sex. Med. 7, 3331–3340 (2010).
Zhang, H. et al. Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties. Biochem. Biophys. Res. Commun. 402, 560–564 (2010).
Gonzalez-Cadavid, N. F. & Rajfer, J. Experimental models of Peyronie's disease. Implications for new therapies. J. Sex. Med. 6, 303–313 (2009).
Lin, G. et al. Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2: Interference in a TGF-beta1/Smad-dependent mechanism and downregulation of AAT1. J. Sex. Med. 7, 1787–1797 (2010).
Albersen, M. et al. Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J. Sex. Med. 9, 385–403 (2012).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares an association with the speakers bureaux for Abbott and Endo and has received a past consultant fee for American Medical Systems.
Rights and permissions
About this article
Cite this article
Shindel, A. The potential of stem cell therapy for Peyronie disease. Nat Rev Urol 10, 8–9 (2013). https://doi.org/10.1038/nrurol.2012.221
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2012.221
